Stanford scientists in the U.S. have formed an immunizer check. They are saying immunizer can reveal whether or not a person infects with the brand new coronavirus. The immunizer is produced by faculty at Stanford Medicine.
According to a report by the Stanford scientist, the test identifies antibodies that the immune system produces to combat coronavirus. It takes some days to get results back.
They use samples from coronavirus victims and also two-year-old blood plasma to check the test.
Professor and chair of pathology on the School of Medicine Dr. Thomas Montine told in a report that viewing for immunizers in blood plasma "gives us a more comprehensive view of what's happening in an individual who is infected, or has been infected, with the virus."
He also confirms the test "isn't a perfect tool, but it's one that I suspect we'll use to help devise protocols for unwinding shelter-in-place orders."
The program could further support studying a possible coronavirus medication known as convalescent plasma therapy. In this immunizers uses for a patient who has survived the disease.
Thomas Montine said that the above approach is important in this type of pandemic where there are no vaccines yet. "That approach could be very important in this period when we don't have vaccines or other definitive therapies."
The tests developed globally, but they can vary in quality, Montine said. "We thought this was an urgent medical need. And the usual supply chains were unreliable, so we decide to build our own."
The immunizer test takes as IgM and IgG antibodies. While data hints coronavirus cases produce the former in the early stages of infection. The latter stages assumes to be in abundance and hold about longer in the body. Montine also advises that the disease is new, we don't know how long immunizers delay.